| DICOM PS3.16 2024d - Content Mapping Resource |
|---|
This Annex specifies the meanings of codes defined in DICOM, either explicitly or by reference to another part of DICOM or an external reference document or standard.
The contents of this table are available in OWL, XRDF and CSV format at ftp://medical.nema.org/medical/dicom/resources/ontology/dcm/dcm.owl and in Bioportal.
Table D-1. DICOM Controlled Terminology Definitions (Coding Scheme Designator "DCM" Coding Scheme Version "01")
|
An acquisition device, process or method that measures autorefraction. |
|||
|
A device, process or method that stores images and other objects for a prolonged period of time. |
|||
|
An acquisition device, process or method that records images during angioscopy. |
|||
|
A device, process or method that produces assessments of the content of other instances, e.g., for quality or suitability. |
|||
|
An acquisition device, process or method that records audio. |
|||
|
An acquisition device, process or method that performs ultrasound bone densitometry. |
|||
|
An acquisition device, process or method that performs biomagnetic imaging. |
|||
|
An acquisition device, process or method that performs bone mineral densitometry by X-Ray, including dual-energy X-Ray absorptiometry (DXA) and morphometric X-Ray absorptiometry (MXA). |
|||
|
An image processing device, process or method that performs computer assisted detection or diagnosis. |
|||
|
An acquisition device, process or method that performs image capture, includes video capture. |
|||
|
An acquisition device, process or method that performs color flow Doppler. |
Replaced by (US, DCM, "Ultrasound") |
||
|
An acquisition device, process or method that performs cinefluorography. |
Replaced by (RF, DCM, "Radiofluoroscopy") |
||
|
An acquisition device, process or method that performs imaging using a confocal microscope. |
|||
|
A device, process or method that performs computation as a service; includes radiotherapy planning. |
|||
|
An acquisition device, process or method that records images during culposcopy. |
|||
|
An acquisition device, process or method that performs computed radiography. |
|||
|
An acquisition device, process or method that records images during cystoscopy. |
|||
|
An acquisition device, process or method that performs computed tomography. |
|||
|
A device, process or method that produces CT device acquisition protocols. |
|||
|
An acquisition device, process or method that performs duplex Doppler. |
Replaced by (US, DCM, "Ultrasound") |
||
|
An acquisition device, process or method that performs digital fluoroscopy. |
Replaced by (RF, DCM, "Radiofluoroscopy") |
||
|
An acquisition device, process or method that performs diaphanography. |
|||
|
An acquisition device, process or method that performs digital microscopy. |
|||
|
An acquisition device, process or method that performs imaging of the surface of the skin using epiluminescence microscopy. |
|||
|
A device, process or method that produces documents. i.e., representations of documents as images, whether by scanning or other means. |
|||
|
A device, process or method that digitizes hardcopy documents and imports them. |
|||
|
An acquisition device, process or method that performs digital subtraction angiography. |
Replaced by (XA, DCM, "X-Ray Angiography") |
||
|
A department-based information system (for instance, Radiology or Laboratory) that provides functions related to the management of orders received from external systems or through the department system’s user interface. This definition matches that of the DSS/OF Actor in the IHE Scheduled Workflow (SWF) Profile. |
|||
|
An acquisition device, process or method that performs digital radiography. |
|||
|
An acquisition device, process or method that performs echocardiography. |
Replaced by (US, DCM, "Ultrasound") |
||
|
An acquisition device, process or method that performs electrocardiography. |
|||
|
An acquisition device, process or method that performs electroencephalography. |
|||
|
An acquisition device, process or method that performs electromyography. |
|||
|
An acquisition device, process or method that performs electrooculography. |
|||
|
An acquisition device, process or method that performs cardiac electrophysiology. |
|||
|
An acquisition device, process or method that records images during endoscopy. |
|||
|
An acquisition device, process or method that performs fluorescein angiography. |
Replaced by (OP, DCM, "Ophthalmic photography") |
||
|
A device, process or method that identifies features or landmarks used to establish spatial correlation between objects or frames of reference. |
|||
|
A device, process or method that performs film digitization. |
|||
|
An acquisition device, process or method that records images during fundoscopy. |
|||
|
An acquisition device, process or method that performs general microscopy. |
|||
|
A device, process or method that creates images to be printed as hard copy. |
|||
|
An acquisition device, process or method that records hemodynamic waveforms. |
|||
|
An acquisition device, process or method that performs intra-oral radiography. |
|||
|
A device, process or method that encodes calculations for an intraocular lens. |
|||
|
An acquisition device, process or method that performs intravascular optical coherence tomography |
|||
|
An acquisition device, process or method that performs intravascular ultrasound. |
|||
|
An acquisition device, process or method that performs keratometry. |
|||
|
A device, process or method that creates Key Object Selection objects. |
|||
|
An acquisition device, process or method that performs lensometry. |
|||
|
A device, process or method that performs procedure Logging; includes cath lab logging. |
|||
|
An acquisition device, process or method that records images during laparoscopy. |
|||
|
An acquisition device, process or method that performs laser surface scanning. |
|||
|
A device, process or method that produces data (models) for use in 3D manufacturing. |
|||
|
An acquisition device, process or method that performs magnetic resonance angiography. |
Replaced by (MR, DCM, "Magnetic resonance") |
||
|
A device, process or method that creates DICOM PS3.10 interchange media. E.g., a CD creator that is managed by the Media Creation Management Service Class. |
|||
|
A device, process or method that retrieves and imports objects from Interchange Media. |
|||
|
An acquisition device, process or method that performs mammography. |
|||
|
An acquisition device, process or method that performs magnetic resonance imaging. |
|||
|
An acquisition device, process or method that performs magnetic resonance spectroscopy. |
Replaced by (MR, DCM, "Magnetic resonance") |
||
|
Instances need to be retrieved from relatively slow media such as optical disk or tape. |
|||
|
An acquisition device, process or method that performs nuclear medicine imaging. |
|||
|
An acquisition device, process or method that measures the axial length of the eye. |
|||
|
An acquisition device, process or method that uses an interferometric, non-invasive optical tomographic technique to image 2D slices and 3D volumes of tissue using visible and near visible frequencies. |
|||
|
An acquisition device, process or method that performs ophthalmic photography. |
|||
|
An acquisition device, process or method that measures corneal topography, corneal or retinal thickness, and other similar parameters that are typically displayed as maps. |
|||
|
An acquisition device, process or method that measures the refractive characteristics of the eye. |
|||
|
An acquisition device, process or method that performs tomography of the eye that is based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded. |
|||
|
An acquisition device, process or method that performs B-scan volume analysis of tomography images of the eye based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded. |
|||
|
An acquisition device, process or method that creates en face tomography images of the eye based on light and optical principles. Tomography based on other principles, such as ultrasound, is excluded. |
|||
|
An acquisition device, process or method that measures visual fields and perform visual perimetry. |
|||
|
An acquisition device, process or method that performs optical surface scanning. |
|||
|
An acquisition device, process or method that performs imaging by means of tissue excitation through the absorption of short light pulses and detection of the resultant acoustic emission. |
|||
|
A device, process or method that produces treatment plans, e.g., delivery instructions for RT. |
|||
|
A device or sensor measuring the orientation of the patient’s body. |
|||
|
A device, process or method that creates Presentation State objects. |
|||
|
Hard Copy Print Server; includes printers with embedded DICOM print server. |
|||
|
An acquisition device, process or method that performs positron emission tomography (PET). |
|||
|
An acquisition device, process or method that performs panoramic X-Rays. |
|||
|
An image processing device, process or method that creates Registration objects. |
|||
|
A device, process or method that produces waveforms of electrical signals from the patient’s respiratory system. |
|||
|
An acquisition device, process or method that performs radiofluoroscopy. |
|||
|
An acquisition device, process or method that performs radiographic imaging (conventional film/screen). |
|||
|
A device, process or method that delivers radiation therapy; includes linear accelerator, proton therapy. |
|||
|
An acquisition device, process or method that performs radiotherapy imaging; includes portal imaging. |
|||
|
A device, process or method that produces radiotherapy plans. |
|||
|
A device, process or method that records radiotherapy treatment records. |
|||
|
A device, process or method that produces Radiotherapy Structure Sets. |
|||
|
A device, process or method that produces mappings between image pixel values and some real-world values. |
|||
|
An image processing device, process or method that performs segmentation. |
|||
|
An acquisition device, process or method that performs slide microscopy. |
|||
|
A device, process or method that records relationships between stereometric image pairs. |
|||
|
A device, process or method that creates Structured Report documents. |
|||
|
An acquisition device, process or method that records subjective refraction. |
|||
|
An acquisition device, process or method that performs single-photon emission computed tomography (SPECT). |
Replaced by (NM, DCM, "Nuclear Medicine") |
||
|
A device, process or method that applies, in an automated manner, a stain, or reagent, to microscopy slides in preparation for imaging. |
|||
|
A device, process or method that produces texture maps. E.g., for use in 3D manufacturing. |
|||
|
An acquisition device, process or method that performs thermography. |
|||
|
An acquisition device, process or method that performs ultrasound. |
|||
|
An acquisition device, process or method that measures visual acuity. |
|||
|
An acquisition device, process or method that measures videofluorography. |
Replaced by (RF, DCM, "Radiofluoroscopy") |
||
|
A device, process or method that digitizes video tape and imports it. |
|||
|
A networked computer equipped with a display and software for performing specific types of work, generally intended to be operated by a single user. |
|||
|
An acquisition device, process or method that performs X-Ray angiography. |
|||
|
An acquisition device, process or method that performs photography with an external camera. |
|||
|
A signal transmitted for the purpose of interchange of the current time, not specific to any source or methodology. |
|||
|
A signal that is generated for each detection of a heart beat. |
|||
|
A signal transmitted by the Inter-Range Instrumentation Group for the purpose of synchronizing time clocks. |
|||
|
A signal that indicates that X-Ray source has been activated for fluoroscopy use. |
|||
|
A signal that indicated that the X-Ray source has been activated for image recording. |
|||
|
An electrophysiological recording from the HIS nerve bundle. |
|||
|
An electrical signal from one electrode relative to an indifferent potential. |
|||
|
Electrophysiological signals acquired using a multi-splined catheter each equipped with multiple electrodes. |
|||
|
Electrophysiological signals acquired using a steerable catheter. |
|||
|
A signal point that is 35% of the peak thermal cardiac output signal. |
|||
|
A signal point that is 70% of the peak thermal cardiac output signal. |
|||
|
The peak pressure of each heart beat in the atrium caused by the atrial contraction. |
|||
|
An identified cardiac beat used in the determination of a measurement. |
|||
|
An identified cardiac beat not used in the determination of a measurement. |
|||
|
Retired. Replaced by (314453003, SCT, "Average diastolic blood pressure") |
|||
|
The lowest pressure value excluding any undershoot artifact. |
Retired. Replaced by (314451001, SCT, "Minimum diastolic blood pressure") |
||
|
The moment at the end of the diastolic phase of the cardiac cycle. |
Retired. Replaced by (416190007, SCT, "End diastole") |
||
|
The average blood pressure value, generally over 2 or more seconds |
Retired. Replaced by (6797001, SCT, "Mean blood pressure") |
||
|
The peak change in blood temperature during a thermal cardiac output measurement. |
|||
|
The first discernible blood temperature change following the injectate during a thermal cardiac output measurement. |
|||
|
The average of several systolic blood pressure measurements. |
Retired. Replaced by (314440001, SCT, "Average systolic blood pressure") |
||
|
The highest systolic blood pressure value excluding any overshoot artifact |
Retired. Replaced by (314439003, SCT, "Maximum systolic blood pressure") |
||
|
The peak pressure of each heart beat in the atrium caused by the filling of the atrium. |
|||
|
The moment in the cardiac cycle when the HIS bundle nerves depolarize. |
|||
|
The first negative deflection of the electrocardiogram cause by ventricular depolarization. |
|||
|
The first positive deflection the electrocardiogram cause by ventricular depolarization. |
|||
|
The beginning of the second atrial contraction of two consecutive beats. |
|||
|
The stimulation interval during cardiac stimulation first used in a pacing train. |
|||
|
The stimulation interval different from the first stimulation interval used in a pacing train. |
|||
|
A stimulation interval different from and subsequent to the second interval in a pacing train. |
|||
|
Describes a stimulation interval different from and subsequent to the third interval in a pacing train. |
|||
|
The electrocardiogram deflection caused by ventricular repolarization. |
|||
|
The peak pressure of each heart beat monitored in the atrium caused by the filling of the atrium. |
|||
|
A description of the physiological condition of the patient. |
|||
|
The exercise level during a progressive cardiac stress test. |
|||
|
A series of physiological challenges designed to progressively increase the work of the heart. |
|||
|
Retired. Replaced by (129085009, SCT, "Catheterization Procedure Phase") |
|||
|
The subpart of a cardiac catheterization procedure in which a radio-opaque contrast medium is injected into the patient. |
|||
|
Physical changes administered to a patient in order to elicit an physiological response. |
|||
|
Retired. Replaced by (416430001, SCT, "End systole") |
|||
|
Time for a median particle to travel from point of injection to point of detection. |
|||
|
Total time for the acquisition is shorter than cardiac cycle, no gating is applied; see Cardiac Synchronization Technique (0018,9037). |
|||
|
Certain thresholds have been set for a gating window that defines the acceptance of measurement data during the acquisition; see Cardiac Synchronization Technique (0018,9037). |
|||
|
Certain thresholds have been set for a gating window that defines the acceptance of measurement data after the acquisition; see Cardiac Synchronization Technique (0018,9037). |
|||
|
There is a constant RR interval, which makes thresholding not required; see Cardiac Synchronization Technique (0018,9037). E.g., Pacemaker. |
|||
|
Imaging after injection of tracer during increased cardiac workload or increased myocardial blood flow, achieved by either exercise or pharmacologic means. |
Retired. Replaced by (432655005, SCT, "Cardiac stress state"). |
||
|
Imaging after injection of additional tracer under resting conditions. |
|||
|
Imaging after allowing a moderate amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging 2-6 hours after injection. |
|||
|
Imaging after allowing an extended amount of time for tracer to move from its initial sites of uptake. Example: For Thallium imaging this would correspond to imaging more than 6 hours after injection. |
|||
|
Retired. Replaced by (434161005, SCT, "Peak stress state") |
|||
|
Retired. Replaced by (432554001, SCT, "Cardiac stress Recovery state") |
|||
|
Equipment that originally acquired the data stored within composite instances. E.g., a CT, MR or Ultrasound modality. |
|||
|
Equipment that has processed composite instances to create new composite instances. E.g., a workstation or software component that performs 3D construction, segmentation or applies an AI model. |
|||
|
Equipment that has modified existing composite instances (without creating new composite instances). E.g., a QA Station or Archive. |
|||
|
Equipment that has modified an existing composite instance to remove patient identifying information. |
|||
|
Equipment that has processed composite instances to create new composite instances by extracting selected frames from the original instance. |
|||
|
Equipment that has processed composite instances to create new composite instances by converting classic single frame images to enhanced multi-frame image, or vice versa and updating other instances to maintain referential integrity. |
|||
|
May include the patient's voice, or the voice of staff present in the room, or an operator's voice (whether for the purpose of recording a narrative accompanying a procedure or not). |
|||
|
The voice of a device operator, recorded during a procedure. |
|||
|
The ambient sound recorded during a procedure, which may or may not include voice and other types of sound. |
|||
|
May include the sound of the heart, but also sound from other organs, such as bowel sounds or bruits from vessels, or sounds of respiration. Not intended to include voice. |
|||
|
A digitized signal from the patient arterial system collected through pulse oximetry or other means. |
|||
|
A digitized signal from the patient respiratory system representing respiration. |
|||
|
The occasion on which a procedure was performed on admission to a specialist unit. E.g., intensive care. |
|||
|
The occasion on which a procedure was performed on discharge from hospital as an in-patient. |
|||
|
The occasion on which a procedure was performed on discharge from a specialist unit. E.g., intensive care. |
|||
|
The occasion on which a procedure was performed immediately prior to non-surgical intervention. E.g, percutaneous angioplasty, biopsy. |
|||
|
The occasion on which a procedure was performed immediately after to non-surgical intervention. E.g, percutaneous angioplasty, biopsy. |
|||
|
The occasion on which a procedure was performed at the most recent outpatient visit. |
|||
|
Evaluation of overall image quality as described in section 7.3.2 of [IEC 62563-1]. |
|||
|
Visual verification of sufficient grayscale resolution based on 8 and 10-bit markers as described in section 7.3.3 of [IEC 62563-1]. |
|||
|
Visual evaluation of luminance response using the TG18-CT test pattern as described in section 7.3.4 of [IEC 62563-1]. |
|||
|
Visual detection of luminance non-uniformities as described in section 7.3.5 of [IEC 62563-1]. |
|||
|
Visual verification of color uniformity as described in section 7.3.6 of [IEC 62563-1]. |
|||
|
Visual detection of defective pixels on dark (TG18-UN80) and bright (TG18-UN10) images as described in section 7.3.7 of [IEC 62563-1]. |
|||
|
Visual evaluation of veiling glare by looking at low contrast objects on 2 test patterns as described in section 7.3.8 of [IEC 62563-1]. |
|||
|
Visual evaluation of geometry, phase/clock correction and clipping as described in section 7.3.9 of [IEC 62563-1]. |
|||
|
Visual evaluation of viewing angle as described in section 7.3.10 of [IEC 62563-1]. |
|||
|
Visual evaluation of the appearance of clinical images as described in section 7.3.11 of [IEC 62563-1]. |
|||
|
AAPM TG18-QC Pattern used for evaluation of resolution, luminance, distortion, artifacts. See [AAPM OR 03]. |
|||
|
AAPM TG18-BR Pattern used for the evaluation of the display of low-contrast, fine-detail image structures See [AAPM OR 03]. |
|||
|
AAPM TG18-PQC Pattern used for evaluation of resolution, luminance, contrast transfer for prints. See [AAPM OR 03]. |
|||
|
AAPM TG18-CT Pattern used for evaluation of luminance response. See [AAPM OR 03]. |
|||
|
The 1st image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 2nd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 3rd image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 4th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 5th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 6th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 7th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 8th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 9th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 10th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration series. See [AAPM OR 03]. |
|||
|
The 11th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 12th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 13th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 14th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 15th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 16th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 17th image in the AAPM TG18-LN8 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 18th image in the AAPM TG18-LN8- set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 1st image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 2 nd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 3rd image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 4th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 5th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 6th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 7th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 8th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 9th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 10th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 11th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 12th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 13th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 14th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 15th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 16th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 17th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The 18th image in the AAPM TG18-LN12 set used for DICOM grayscale calibration. See [AAPM OR 03]. |
|||
|
The AAPM TG18-UN10 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]. |
|||
|
The AAPM TG18-UN80 Pattern used for evaluation of luminance and color uniformity, and angular response. See [AAPM OR 03]. |
|||
|
The AAPM TG18-UNL10 Pattern is the AAPM TG-18 UN10 Pattern with added defining lines. See [AAPM OR 03]. |
|||
|
The AAPM TG18-UNL80 Pattern is the AAPM TG-18 UN80 Pattern with added defining lines. See [AAPM OR 03]. |
|||
|
The AAPM TG18-AD Pattern used for visual evaluation of the reflection of ambient light from the display. See [AAPM OR 03]. |
|||
|
The AAPM TG18-MP Pattern used for evaluation of Luminance response (bit-depth resolution). See [AAPM OR 03]. |
|||
|
The AAPM TG18-RH10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 10% luminance level. See [AAPM OR 03]. |
|||
|
The AAPM TG18-RH50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 50% luminance level. See [AAPM OR 03]. |
|||
|
The AAPM TG18-RH89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 horizontal lines at 89% luminance level. See [AAPM OR 03]. |
|||
|
The AAPM TG18-RV10 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 10% luminance level. See [AAPM OR 03]. |
|||
|
The AAPM TG18-RV50 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 50% luminance level. See [AAPM OR 03]. |
|||
|
The AAPM TG18-RV89 Pattern used for LSF-line spectra function-(1k and 2k) evaluation by 5 vertical lines at 89% luminance level. See [AAPM OR 03]. |
|||
|
The AAPM TG18-PX Pattern used for the assessment of display resolution. See [AAPM OR 03]. |
|||
|
The AAPM TG18-CX Pattern used to assess display resolution and resolution uniformity. See [AAPM OR 03]. |
|||
|
The AAPM TG18-LPH10 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]. |
|||
|
The AAPM TG18-LPH50 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 50% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]. |
|||
|
The AAPM TG18-LPH89 Pattern used to assess display resolution. This pattern has horizontal bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]. |
|||
|
The AAPM TG18-LPV10 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 10% background level of the maximum pixel value. See [AAPM OR 03]. |
|||
|
The AAPM TG18-LPV50 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 50% background level of the maximum pixel value. See [AAPM OR 03]. |
|||
|
The AAPM TG18-LPV89 Pattern used to assess display resolution. This pattern has vertical bars consisting of alternating single-pixel-wide lines across the faceplate of display. The lines have a 12% positive contrast against 89% background level of the maximum pixel value. See [AAPM OR 03]. |
|||
|
The AAPM TG18-AFC Pattern used to assess display noise. See [AAPM OR 03] |
|||
|
The AAPM TG18-NS10 Pattern is AAPM TG18-RV10/RH10 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]. |
|||
|
The AAPM TG18-NS50 Pattern is AAPM TG18-RV50/RH50 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]. |
|||
|
The AAPM TG18-NS89 Pattern is AAPM TG18-RV89/RH89 with only difference being the absence of the single line at the center of the measurement area. See [AAPM OR 03]. |
|||
|
The TG18-GV Pattern used to assess display veiling. See [AAPM OR 03]. |
|||
|
The TG18-GVN Pattern used to assess display veiling. This pattern is identical to AAPM TG18-GV Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]. |
|||
|
The TG18-GQ Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GV except that is lacks the central low-contrast objects. See [AAPM OR 03]. |
|||
|
TG18-GQN Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except that the large-diameter white circle is replaced with a black circle, creating a completely black pattern except for the presence of low-contrast targets. See [AAPM OR 03]. |
|||
|
The TG18-GQB Pattern used for the quantitative assessment of veiling glare. This pattern is identical to AAPM TG18-GQ Pattern except eliminating the central black circle. See [AAPM OR 03]. |
|||
|
The TG18-GA03 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 3. See [AAPM OR 03]. |
|||
|
The TG18-GA05 Pattern This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 5. See [AAPM OR 03]. |
|||
|
The TG18-GA08 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 8. See [AAPM OR 03]. |
|||
|
The TG18-GA10 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 10. See [AAPM OR 03]. |
|||
|
The TG18-GA15 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 15. |
|||
|
The TG18-GA20 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 20. See [AAPM OR 03]. |
|||
|
The TG18-GA25 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 25. See [AAPM OR 03]. |
|||
|
The TG18-GA30 Pattern used for quantitative assessment of veiling glare. This pattern is identical to TG18-GQ except that the radius of the central black circle is varied as r = 30. See [AAPM OR 03]. |
|||
|
The AAPM TG18-CH Image is a reference anatomical PA chest image. See [AAPM OR 03]. |
|||
|
The AAPM TG18-KN Image is a reference anatomical knee image. See [AAPM OR 03]. |
|||
|
The AAPM TG18-MM1 Image is a reference anatomical mammogram image. See [AAPM OR 03]. |
|||
|
The AAPM TG18-MM2 Image is a reference anatomical mammogram image. See [AAPM OR 03]. |
|||
|
The IEC OIQ Pattern is used as an alternative to the TG18-QC Pattern. See [IEC 62563-1]. |
|||
|
The IEC ANG Pattern used for angular viewing evaluation. See [IEC 62563-1]. |
|||
|
The IEC GD Pattern used for geometrical image evaluation. See [IEC 62563-1]. |
|||
|
The IEC BN01 Pattern is used as an alternative to the TG18-LN-01 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN02 Pattern is used as an alternative to the TG18-LN-02 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN03 Pattern is used as an alternative to the TG18-LN-03 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN04 Pattern is used as an alternative to the TG18-LN-04 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN05 Pattern is used as an alternative to the TG18-LN-05 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN06 Pattern is used as an alternative to the TG18-LN-06 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN07 Pattern is used as an alternative to the TG18-LN-07 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN08 Pattern is used as an alternative to the TG18-LN-08 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN09 Pattern is used as an alternative to the TG18-LN-09 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN10 Pattern is used as an alternative to the TG18-LN-10 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN11 Pattern is used as an alternative to the TG18-LN-11 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN12 Pattern is used as an alternative to the TG18-LN-12 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN13 Pattern is used as an alternative to the TG18-LN-13 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN14 Pattern is used as an alternative to the TG18-LN-14 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN15 Pattern is used as an alternative to the TG18-LN-15 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN16 Pattern is used as an alternative to the TG18-LN-16 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN17 Pattern is used as an alternative to the TG18-LN-17 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
The IEC BN18 Pattern is used as an alternative to the TG18-LN-18 Pattern, to avoid the use of a cone or baffle with LCDs. See [IEC 62563-1]. |
|||
|
Test image "Bild 2" for the gray-scale reproduction of imaging devices. See [DIN 6868-57]. |
|||
|
Test image "Bild 3" for the geometrical imaging properties of imaging devices. See [DIN 6868-57]. |
|||
|
Test image "Bild 5" for displaying the spatial and contrast resolution as well as the line structure of imaging devices. See [DIN 6868-57]. |
|||
|
An alternative to AAPM TG18-UN80, specified at 100% of maximum pixel value. |
|||
|
A standard display test pattern. See [SMPTE RP133]. A pattern is available at http://www.dclunie.com/images/smpte.512.512.8.gif. |
|||
|
A Display Device that displays images on a Cathode Ray Tube. |
|||
|
A Display Device that displays images on a Liquid Crystal Display. |
|||
|
A Display Device that displays images on an Organic Light Emitting Diode based display. |
|||
|
A Display Device that projects images on a surface from behind using a Digital Light Processing Projector. |
|||
|
A Display Device that projects images on a surface from in front using a Digital Light Processing Projector. |
|||
|
A Display Device that projects images on a surface from behind using a Cathode Ray Tube. |
|||
|
A Display Device that projects images on a surface from in front using a Cathode Ray Tube. |
|||
|
A Display Device that projects images on a surface from an unspecified direction using an unspecified means. |
|||
|
The work item task is to prepare a report that contains the interpretation of an imaging study. |
|||
|
The procedure to read DICOM instances from DICOM interchange media, coerce identifying Attributes into the local namespace if necessary, and make the instances available. |
|||
|
Digitization of pages of a paper document (Units may be specified as Pages, Documents). |
|||
|
A device that connects using the USB hard drive interface. These may be USB-Sticks, portable hard drives, and other technologies. |
|||
|
Email and email attachments used as a media for data transport. |
|||
|
DVD, DVD-RAM, and other DVD formatted media used for data transport. |
|||
|
Audit event: DICOM Instances have been created, read, updated, or deleted -audit event. |
|||
|
Audit event: Order has been created, read, updated or deleted. |
|||
|
Audit event: Patient Record has been created, read, updated, or deleted. |
|||
|
Audit event: Procedure Record has been created, read, updated, or deleted. |
|||
|
Audit event: A use of a restricted function has been attempted. |
|||
|
Audit event: Security attributes of an object have been changed. |
|||
|
Audit event: Security attributes of a user have been changed. |
|||
|
Audit participant role ID of software application launcher, i.e., the entity that started or stopped an application. |
|||
|
Audit participant role ID of media receiving data during an export. |
|||
|
Audit participant role ID of media providing data during an import. |
|||
|
ID of a node that is a participant object of an audit message. |
|||
|
System, organization, agency, or department that has assigned an instance identifier (such as placer or filler number, patient or provider identifier, etc.). |
|||
|
Procedure order canceled by requesting physician or other authorized physician. |
|||
|
Procedure discontinued due to incorrect procedure being ordered. |
|||
|
Procedure discontinued due to patient allergy to media/contrast (reported or reaction). |
|||
|
Procedure discontinued due to patient refusal to continue procedure. |
|||
|
Procedure discontinued due to patient being taken for treatment or surgery. |
|||
|
Procedure discontinued due to patient pregnancy (reported or determined). |
|||
|
Procedure discontinued to restart with new procedure code for correct charging. |
|||
|
Procedure discontinued due to duplicate orders received for same procedure. |
|||
|
Procedure discontinued due to incorrect side (laterality) being ordered. |
|||
|
Procedure discontinued due to incorrect patient or procedure step selected from modality worklist. |
|||
|
Procedure step is discontinued to change to other equipment or modality. |
|||
|
A movement of the patient preventing continuation of procedure or affecting result quality. |
|||
|
An error of the operator preventing continuation of procedure or affecting result quality. |
|||
|
The brachytherapy channel is obstructed and the treatment in this channel cannot proceed. |
|||
|
One or more objects associated with the object set is missing. |
|||
|
Procedure discontinued due to necessary equipment, staff or other resource becoming (temporarily) unavailable to the procedure. |
|||
|
Procedure discontinued due to necessary equipment, staff or other resource being inadequate to complete the procedure. |
|||
|
A new Procedure Step has been scheduled to replace the Discontinued Procedure Step. |
|||
|
It is recommended that a new Procedure Step be scheduled to replace the Discontinued Procedure Step. |
|||
|
The resource to which a workitem has been assigned has rejected the assignment. |
|||
|
Reporting not possible due to lack of quality of the images provided. |
|||
|
The nature of the clinical problem means that reporting of the study requires a subject matter expert. |
|||
|
Ventral structures of the diencephalon that cannot readily be distinguished on MR imaging, including the hypothalamus, mammillary body, subthalamic nuclei, substantia nigra, red nucleus, lateral geniculate nucleus, medial geniculate nucleus, zona incerta, cerebral peduncle, lenticular fasciculus, medial lemniscus, and optic tract. See http://neuromorphometrics.org:8080/Seg/html/segmentation/ventral%20diencephalon.html and http://www.cma.mgh.harvard.edu/manuals/segmentation/. |
|||
|
Area(s) of reduced intensity on T1 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T2 hyperintensity, but the concept is specifically confined to the MR appearance on T1 weighted images. |
|||
|
Area(s) of increased intensity on T2 weighted images relative to the surrounding white matter. These may be indicative of age-related or neurodegenerative white matter lesions, and may be co-located with areas of white matter T1 hypointensity, but the concept is specifically confined to the MR appearance on T2 weighted images. |
|||
|
The dorsal component of the SLF originating from the medial and dorsal parietal cortex and ending in the dorsal and medial part of the frontal lobe. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186. |
|||
|
The major component of the SLF, derived from the caudal-inferior parietal region corresponding to the angular gyrus in the human and terminating within the dorsolateral frontal region. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186. |
|||
|
The ventral component of the SLF, originating from the supramarginal gyrus and terminating predominantly in the ventral premotor and prefrontal areas. See Makris N, et al. "Segmentation of Subcomponents within the Superior Longitudinal Fascicle in Humans: A Quantitative, In Vivo, DT-MRI Study." Cerebral Cortex 15, no. 6 (June 1, 2005): 854-69. doi:10.1093/cercor/bhh186. |
|||
|
White matter that surrounds a lesion of interest. E.g., to identify the otherwise unclassified white matetr that surrounds a tumor to be surgically resected. |
|||
|
Signal intensity of a Spin tagging Perfusion MR image. Spin tagging is a technique for the measurement of blood perfusion, based on magnetically labeled arterial blood water as an endogenous tracer. |
|||
|
Signal intensity of a Time-of-flight (TOF) MR image. Time-of-flight (TOF) is based on the phenomenon of flow-related enhancement of spins entering into an imaging slice. As a result of being unsaturated, these spins give more signal that surrounding stationary spins. |
|||
|
Signal intensity of a Proton Density Weighted MR image. All MR images have intensity proportional to proton density. Images with very little T1 or T2 weighting are called 'PD-weighted'. |
|||
|
Signal intensity of T1 Weighted MR image. A T1 Weighted MR image is created typically by using short TE and TR times. |
|||
|
Signal intensity of a T2 Weighted MR image. T2 Weighted image contrast state is approached by imaging with a TR long compared to tissue T1 (to reduce T1 contribution to image contrast) and a TE between the longest and shortest tissue T2s of interest. |
|||
|
Signal intensity of a T2* Weighted MR image. The T2* phenomenon results from molecular interactions (spin spin relaxation) and local magnetic field non-uniformities, which cause the protons to precess at slightly different frequencies. |
|||
|
Signal intensity of a Field Map MR image. A Field Map MR image provides a direct measure of the B 0 inhomogeneity at each point in the image. |
|||
|
Coefficient reflecting the fractional anisotropy of the tissues, derived from a diffusion weighted MR image. Fractional anisotropy is proportional to the square root of the variance of the Eigen values divided by the square root of the sum of the squares of the Eigen values. |
Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996 Jun;111(3):209-19. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.162.2222&rep=rep1&type=pdf |
||
|
Coefficient reflecting the relative anisotropy of the tissues, derived from a diffusion weighted MR image. |
Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996 Jun;111(3):209-19. http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.162.2222&rep=rep1&type=pdf |
||
|
Dxx Component of the diffusion tensor, quantifying the molecular mobility along the X axis. |
|||
|
Dxy Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Y directions. |
|||
|
Dxz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the X and Z directions. |
|||
|
Dyy Component of the diffusion tensor, quantifying the molecular mobility along the Y axis. |
|||
|
Dyz Component of the diffusion tensor, quantifying the correlation of molecular displacements in the Y and Z directions. |
|||
|
Dzz Component of the diffusion tensor, quantifying the molecular mobility along the Z axis. |
|||
|
Signal intensity of a T1 Weighted Dynamic Contrast Enhanced MR image. A T1 Weighted Dynamic Contrast Enhanced MR image reflects the dynamics of diffusion of the exogenous contrast media from the blood pool into the extra vascular extracellular space (EES) of the brain at a rate determined by the blood flow to the tissue, the permeability of the Brain Blood Barrier (BBB), and the surface area of the perfusing vessels. |
|||
|
Signal intensity of a T2 Weighted Dynamic Contrast Enhanced MR image. A T2 Weighted Dynamic Contrast Enhanced MR image reflects the T2 of tissue decrease as the Gd contrast agent bolus passes through the brain. |
|||
|
Signal intensity of a T2* Weighted Dynamic Contrast Enhanced MR image. A T2* Weighted Dynamic Contrast Enhanced MR image reflects the T2* of tissue decrease as the Gd contrast agent bolus passes through the brain. |
|||
|
Signal intensity of a Blood Oxygenation Level image. Used in Photoacoustic Imaging and functional MR. In functional MR BOLD imaging it is used for detecting brain activation and is sensitive to blood oxygenation (but also to cerebral blood flow and volume). |
|||
|
Accumulated decay event counts in a nuclear medicine projection image. |
|||
|
Accumulated decay event counts in a Nuclear Medicine Tomographic image (including PET). |
|||
|
Spatial Displacement along axis X of a non linear deformable spatial registration image. The X axis is defined in reference to the patient's orientation, and is increasing to the left hand side of the patient. |
|||
|
Spatial Displacement along axis Y of a non linear deformable spatial registration image. The Y axis is defined in reference to the patient's orientation, and is increasing to the posterior side of the patient. |
|||
|
Spatial Displacement along axis Z of a Non linear deformable spatial registration image. The Z axis is defined in reference to the patient's orientation, and is increasing toward the head of the patient. |
|||
|
Measured resistance to the flow of blood. E.g., through the vasculature or through a heart value. |
|||
|
Measured resistance to the flow of blood. E.g., through the vasculature or through a heart value, normalized to a particular indexed scale. |
|||
|
Scalar value related to the elastic properties of the tissue. |
|||
|
Scalar value related to the volume of blood perfusing into tissue. |
|||
|
Y (Luminance) component of a YBR FULL image, as defined in JPEG 2000. |
|||
|
CB (Blue chrominance) component of a YBR FULL image, as defined in JPEG 2000. |
|||
|
CR (Red chrominance) component of a YBR FULL image, as defined in JPEG 2000. |
|||
|
Y (Luminance) component of a YBR PARTIAL image, as defined in JPEG 2000. |
|||
|
CB (Blue chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000. |
|||
|
CR (Red chrominance) component of a YBR PARTIAL image, as defined in JPEG 2000. |
|||
|
Y (Luminance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000. |
|||
|
CB (Blue chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000. |
|||
|
CR (Red chrominance) component of a YBR ICT image (Irreversible Color Transform), as defined in JPEG 2000. |
|||
|
Y (Luminance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000. |
|||
|
CB (Blue chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000. |
|||
|
CR (Red chrominance) component of a YBR RCT image (Reversible Color Transform), as defined in JPEG 2000. |
|||
|
The ability of a material to create an ultrasound return echo. |
|||
|
Decrease in the number of photons in an X-Ray beam due to interactions with the atoms of a material substance. Attenuation is due primarily to two processes, absorption and scattering. |
|||
|
Coefficient that describes the fraction of a beam of X-Rays or gamma rays that is absorbed or scattered per unit thickness of the absorber. This value basically accounts for the number of atoms in a cubic cm volume of material and the probability of a photon being scattered or absorbed from the nucleus or an electron of one of these atoms. |
Retired. Replaced by (112031, DCM, "Attenuation Coefficient"). |
||
|
Binary value denoting that the segmented property is present. |
|||
|
Probability, defined as a percentage, that the segmented property occupies the spatial area defined by the voxel. |
|||
|
Percentage of the voxel area occupied by the segmented property. |
|||
|
Dimension denoting the energy (frequency or wavelength) of photons. |
|||
|
Dimension used to sequence events, to compare the duration of events and the intervals between events. |
|||
|
A spatial dimension axis running along a line between the patient's left and right side. |
|||
|
A spatial dimension axis running along a line between the patient's head and foot. |
|||
|
A spatial dimension axis running along a line between the patient's anterior and posterior sides. |
|||
|
A spatial dimension axis running along a line between the apex and base of an organ, object, or chamber. |
|||
|
A spatial dimension axis running along a line between the anterior and inferior sides of an organ, object, or chamber. |
|||
|
A spatial dimension axis running along a line between the septum and wall of a chamber. |
|||
|
Orientation of a spatial dimension where increasing values run from the right to the left side of the patient. |
|||
|
Orientation of a spatial dimension where increasing values run from the left to the right side of the patient. |
|||
|
Orientation of a spatial dimension where increasing values run from the head to the foot of the patient. |
|||
|
Orientation of a spatial dimension where increasing values run from the foot to the head of the patient. |
|||
|
Orientation of a spatial dimension where increasing values run from the anterior to the posterior side of the patient. |
|||
|
Orientation of a spatial dimension where increasing values run from the posterior to the anterior side of the patient. |
|||
|
Orientation of a spatial dimension where increasing values run from the apex to the base. |
|||
|
Orientation of a spatial dimension where increasing values run from the base to the apex. |
|||
|
Orientation of a spatial dimension where increasing values run from the anterior to the inferior. |
|||
|
Orientation of a spatial dimension where increasing values run from the inferior to the anterior. |
|||
|
Orientation of a spatial dimension where increasing values run from the septum of a chamber to the opposite wall. |
|||
|
Orientation of a spatial dimension where increasing values run from the opposite wall to the septum of a chamber. |
|||
|
The x coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system. |
|||
|
The y coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system. |
|||
|
The z coordinate of the upper left hand corner (center of the first voxel transmitted) of the image, with respect to the patient-based coordinate system. |
|||
|
The x value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system. |
|||
|
The y value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system. |
|||
|
The z value of the first row direction cosine with respect to the patient, with respect to the patient-based coordinate system. |
|||
|
The x value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system. |
|||
|
The y value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system. |
|||
|
The z value of the first column direction cosine with respect to the patient, with respect to the patient-based coordinate system. |
|||
|
The family of algorithm(s) that best describes the software algorithm used. |
|||
|
The name assigned by a manufacturer to a specific software algorithm. |
|||
|
The input parameters used by a manufacturer to configure the behavior of a specific software algorithm. |
|||
|
The software version identifier assigned by a manufacturer to a specific software algorithm. |
|||
|
The type of correlation applied to detection results. E.g., temporal, spatial. |
|||
|
Assignment of intermediate or overall interpretation results to a general category. |
|||
|
Assessment of annotating tissues in breast; generally including fatty, mixed or dense |
Retired. Replaced by (129715009, SCT, "Breast composition"). |
||
|
Purpose of reference for an SCOORD Content Item that is an outline of the breast that includes the pectoral muscle tissue |
Purpose of Reference for Content Item of value type COMPOSITE or SCOORD |
||
|
The type of distribution associated with detected calcifications. |
|||
|
Identification of the morphology of detected calcifications. |
|||
|
May be used as the Purpose of Reference for Content Item of value type COMPOSITE or SCOORD, or a qualitative observation on an ROI. |
|||
|
The likelihood that the feature analyzed is in fact the type of feature identified. |
|||
|
The likelihood that the finding detected is in fact the type of finding identified. |
|||
|
The certainty that a device places on an impression, where 0 equals no certainty and 100 equals certainty. |
|||
|
A location identifier based on clockface numbering or anatomic subregion. |
|||
|
An item that is an inferred correlation relating two or more individual findings or features. |
|||
|
The inferred relationship between the findings or features making up a composite feature. |
|||
|
General assessment of whether or not CAD processing was successful, and whether any findings resulted. |
|||
|
A location identifier based on a feature's inferred distance from the surface of the associated anatomy. |
|||
|
A textual description of the change that occurred over time in a qualitative characteristic of a feature. |
|||
|
The type of finding sought after by a specific algorithm applied to one image. |
|||
|
A general change that occurred within an imaged area between a prior imaging procedure and the current imaging procedure. |
|||
|
A group of analysis algorithms that were attempted, but failed. |
|||
|
A group of detection algorithms that were attempted, but failed. |
|||
|
For projection radiography, the horizontal physical distance measured at the front plane of an Image Receptor housing between the center of each pixel (spacing between the centers of adjacent columns). For tomographic images, the horizontal physical distance in the patient between the center of each pixel. |
|||
|
Laterality of (possibly paired) body part contained in an image. |
|||
|
A container that references all image data used as evidence to produce a report. |
|||
|
A numeric value in the range 0 to 100, inclusive, where 0 is worst quality and 100 is best quality. |
|||
|
Purpose of reference for an SCOORD Content Item that identifies a specific region of interest within an image |
Purpose of Reference for Content Item of value type COMPOSITE or SCOORD |
||
|
The projection of the anatomic region of interest on an image receptor. |
|||
|
Free-form text describing the overall or an individual impression. |
|||
|
A container for a group of related results from interpretation of one or more images and associated clinical information. |
|||
|
The X-Ray attenuation of a lesion relative to the expected attenuation of an equal volume of fibroglandular breast tissue. |
|||
|
A structured report containing the results of computer-aided detection or diagnosis applied to breast imaging and associated clinical information. |
|||
|
The characteristic of the boundary, edges or border of a detected lesion. |
|||
|
The quantity of calcifications detected within an identified group or cluster. |
|||
|
Purpose of reference for a COMPOSITE Content Item that identifies it as the original source of evidence for another Content Item in the report |
Purpose of Reference for Content Item of value type COMPOSITE or SCOORD |
||
|
May be used as the Purpose of Reference for Content Item of value type COMPOSITE or SCOORD, or a qualitative observation on an ROI. |
|||
|
The inferred type of disease associated with an identified feature. |
|||
|
The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive column axis (top to bottom). |
|||
|
The patient orientation relative to the image plane, specified by a value that designates the anatomical direction of the positive row axis (left to right). |
|||
|
Purpose of reference for an SCOORD Content Item that is an outline of the pectoral muscle tissue only |
Purpose of Reference for Content Item of value type COMPOSITE or SCOORD |
||
|
Percent of breast area that is mammographically dense, excluding pectoralis muscle. |
|||
|
The likelihood that an identified finding or feature is cancerous. |
|||
|
A location identifier based on the division of an area into four regions. |
|||
|
A qualitative characteristic of a feature that has changed over time. |
|||
|
The quality control standard used to make a quality assessment. |
|||
|
A specific quality related deficiency detected within an image. |
|||
|
Recommended type of follow-up to an imaging procedure, based on interpreted results. |
|||
|
Recommended follow-up date to an imaging procedure, based on interpreted results. |
|||
|
Recommended follow-up interval to an imaging procedure, based on interpreted results. |
|||
|
The recommendation of the producer of a Content Item regarding presentation of the Content Item by recipients of the report. |
|||
|
An indication of how widespread the detection of a feature is within the analyzed image data. |
|||
|
A textual description of the contents of a selected region identified within an image. |
|||
|
Date on which the acquisition of the study information was started. |
|||
|
Time at which the acquisition of the study information was started. |
|||
|
A group of analysis algorithms that were attempted and completed successfully. |
|||
|
A group of detection algorithms that were attempted and completed successfully. |
|||
|
An overall indication of whether the CAD detection algorithms applied were completed successfully. |
|||
|
An overall indication of whether the CAD analysis algorithms applied were completed successfully. |
|||
|
For projection radiography, the vertical physical distance measured at the front plane of an Image Receptor housing between the center of each pixel (spacing between the centers of adjacent rows). For tomographic images, the vertical physical distance in the patient between the center of each pixel. |
|||
|
A radiographic projection that has been with the patient lying on a table with the X-Ray source on one side of the table and the detector on the other. E.g., may describe a cross-table cervical spine, chest or pelvis X-Ray image. |
|||
|
One of a number of discrete points on the Receiver-Operator Characteristics (ROC) curve that reflects the expected sensitivity and specificity of a CAD algorithm, where zero indicates the highest specificity, lowest sensitivity operating point. The value should not exceed the Maximum CAD Operating Point. |
|||
|
The maximum value of CAD Operating Point for the specific CAD algorithm used. |
|||
|
The number of false CAD markers per image. Correlates to inverse of Image Specificity. |
|||
|
The number of false markers per collection of images that are CAD processed as a group. Correlates to inverse of Case Specificity. |
|||
|
The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in at least one view. |
|||
|
The percentage of cancers that should be detected by a CAD algorithm where CAD marks the cancers in each view. |
|||
|
The percentage of cases (collections of images CAD processed as a group) without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Case. |
|||
|
The percentage of images without cancer that have no CAD findings whatsoever. Correlates to inverse of False Markers per Image. |
|||
|
The CAD operating point that is recommended for initial display by the creator of the structured report. |
|||
|
A list of CAD operating points including their corresponding characteristics. |
|||
|
The surface shape of all or a portion of breast related anatomy. |
|||
|
Image quality incorporates the following clinical image evaluation parameters: assessment of positioning, compression, artifacts, exposure, contrast, sharpness, and labeling. |
|||
|
A finding or feature that is identified as a non-anatomic foreign object. |
|||
|
A space-occupying lesion identified in a single image or projection |
Retired. Replaced by (129793001, SCT, "Mammography breast density"). |
||
|
Retired. Replaced by (129770007, SCT, "Individual Calcification"). |
|||
|
Multiple calcifications identified as occupying a small area of tissue (less than 2 cc) |
Retired. Replaced by (129769006, SCT, "Calcification Cluster"). |
||
|
An abnormality noted at imaging within the dermis of the breast. |
|||
|
An abnormality noted at imaging on the epidermis of the breast. |
|||
|
An assessment category to indicate that images have been acquired to assess marker placement following a breast interventional procedure. |
|||
|
An indication that the patient should seek post procedural follow-up directives from a clinical health care provider. |
|||
|
A recommendation on a patient with known cancer to take steps appropriate to the diagnosis. |
|||
|
Patient has previous diagnosis of breast cancer resulting in mastectomy. |
|||
|
Patient has a finding of mass reported on a prior imaging study. |
|||
|
A breast imaging procedure performed on a specific area of the breast. |
|||
|
A cluster of tiny anechoic foci each smaller than 2-3 mm in diameter with thin (less than 0.5 mm) intervening septations and no discrete solid components. |
|||
|
A fluid filled mass most commonly characterized by homogeneous low-level internal echoes on ultrasound. |
|||
|
A spot or coned down compression of the breast providing a reduction in the thickness and a magnification of the localized area of interest and improved separation of breast tissue. |
|||
|
Retired. Replaced by (16310003, SCT, "Diagnostic ultrasonography"). |
|||
|
Obtain previous mammography studies to compare to present study. |
|||
|
A medical procedure used for the sampling of mammary duct tissue |
Retired. Replaced by (18102001, SCT, "Mammary ductogram"). |
||
|
Follow up study at 12 months for women ≥ 40 years of age having a prior negative study and no mitigating risk factors for breast cancer. |
|||
|
Any decision to biopsy should be based on clinical assessment |
Any decision to perform tissue acquisition should be based on clinical assessment. |
||
|
Breast tissue acquisition following the identification of an area of concern with the placement of a needle or needle-wire assembly. |
|||
|
Pathologic analysis of breast tissue and lesions using core tissue samples. |
|||
|
Lesions that do not have the characteristic morphologies of breast cancer but have a definite probability of being malignant. There is a sufficient concern to urge a biopsy. |
|||
|
Lesions have a high probability of being cancer, which require additional action. |
|||
|
Presentation Required: Rendering device is expected to present |
The producer of a report intends for a recipient of the report to present or display the associated Content Item. |
||
|
The producer of a report considers the presentation or display of the associated Content Item by a recipient to be optional. |
|||
|
Not for Presentation: Rendering device expected not to present |
The producer of a report intends for a recipient of the report NOT to present or display the associated Content Item. |
||
|
The associated Content Items are identified as being the same finding or feature at different points in time. |
|||
|
The associated Content Items are identified as being the same finding or feature on different projections taken at the same point in time. |
|||
|
The associated Content Items are identified as being related side-to-side. |
|||
|
There is more than one image of the same modality in the interpreted data. |
|||
|
There is more than one image of the same modality in the interpreted data. |
|||
|
The interpreted data contains images from multiple modalities. |
|||
|
The fibrous tissue replacing normal tissues destroyed by disease or injury |
Retired. Replaced by (12402003, SCT, "Scar tissue"). |
||
|
A medical appliance used for localization of non palpable breast lesions to insure that the proper area is removed in a surgical biopsy |
Retired. Replaced by (129463006, SCT, "J Wire"). |
||
|
Retired. Replaced by (14106009, SCT, "Cardiac Pacemaker"). |
|||
|
Retired. Replaced by (129460009, SCT, "Compression paddle"). |
|||
|
Retired. Replaced by (228761004, SCT, "Collimator"). |
|||
|
An area designated on a radiographic film for facility and patient ID information |
Retired. Replaced by (129467007, SCT, "ID Plate"). |
||
|
This term may not be used in Context Group Extensions; see Section 7.2.3 |
|||
|
View and Laterality Marker does not have both view and laterality |
|||
|
Flash doesn't include patient name and additional patient id |
|||
|
Flash doesn't include cassette/screen/detector identification |
|||
|
MLO No fat is visualized posterior to fibroglandular tissues |
|||
|
CC Posterior nipple line does not measure within 1 cm of MLO |
|||
|
Signals that do not faithfully reproduce actual anatomic structures because of distortion or of addition or deletion of information. |
|||
|
Feature(s) arising from the acquisition unit's anti-scatter grid mechanism. For two-dimensional systems, such features include those of mechanically damaged or incorrectly positioned grids. For moving or Bucky grids, artifacts may result from intentional grid motion that is inadequate in duration or velocity uniformity. |
|||
|
Inadequate arrangement of the anatomy of interest with respect to the X-Ray field and image detector sensitive area. Examples: 1) positioning is "cutoff" when the projection of anatomy of interest falls outside the sensitive area of the detector; 2) "cone cut", in which the X-Ray field does not adequately cover the anatomy of interest; 3) detector's sensitive surface is too small to cover the projection of the anatomy of interest; 4) improper angular orientation or "rotation" of anatomy of interest with respect to the X-Ray source, or detector; 5) projection of other anatomy or clothing over the anatomy of interest in the image. |
|||
|
Unacceptable image blur resulting from motion of the anatomy of interest during exposure or the inadequately compensated motion of X-Ray source with respect to the image detector during exposure. |
|||
|
Inadequate number of quanta reached the detector during exposure. Reasons for under exposed images include low kVp, low mAs product, excess Source Image Distance. Under exposed images have inadequate signal and higher noise in the areas of interest. |
|||
|
An excess number of quanta reached the detector during exposure. Reasons for over exposed images include high kVp, high mAs product, short Source Image Distance. Over exposed images have high signal and lower noise in the areas of interest. Over exposed area may demonstrate lack of contrast from over saturation of the detector. |
|||
|
Features or discontinuities arising from causes other than the anti-scatter grid and image detector. |
|||
|
Failure of the device to operate according to mechanical design specifications. |
|||
|
Failure of a device to operate according to electrical design specifications. |
|||
|
Attributable to software used in generation or handling of image. |
|||
|
Images processed inappropriately, not following appropriate protocol. |
|||
|
Failure that is not mechanical or electrical or otherwise described. |
|||
|
The attempted process succeeded in some ways, but failed in others. |
|||
|
Analysis of a related group of findings or features detected during image data inspection, to produce a summary impression and/or recommendation. |
|||
|
Analysis of all groups of findings or features, to produce a single impression and/or recommendation. |
|||
|
Quality of an image renders it unusable for the intended purpose. |
|||
|
Quality of an image is usable for the intended purpose, but does not meet the quality control standard. |
|||
|
Quality of an image is usable for the intended purpose and meets the quality control standard. |
|||
|
An image quality control standard specified by the American College of Radiology. |
|||
|
An image quality control standard in the US Code of Federal Regulations. |
|||
|
An image quality control standard specified or adopted by the institution responsible for the document. |
|||
|
No findings resulted upon successful completion of all attempted computer-aided detection and/or analysis. |
|||
|
One or more findings resulted upon successful completion of all attempted computer-aided detection and/or analysis. |
|||
|
No findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process. |
|||
|
One or more findings resulted from the attempted computer-aided detection and/or analysis, but one or more failures occurred in the process. |
|||
|
All of the attempted computer-aided detection and/or analysis failed, so there could be no findings. |
|||
|
A benign tumor having glandular characteristics but composed of fat, with the presence of normal mammary ducts |
Retired. Replaced by (22024005, SCT, "Adenolipoma"). |
||
|
Retired. Replaced by (67617000, SCT, "Ductal hyperplasia, Usual"). |
|||
|
Retired. Replaced by (128765009, SCT, "Adenomyoepithelioma"). |
|||
|
Axillary node that is normal in appearance with no associated pathology. |
|||
|
Excessive proliferation of normal tissue arrangement of the axillary node. |
|||
|
Retired. Replaced by (130963002, SCT, "Asynchronous involution of breast"). |
|||
|
Calcifications having typically benign morphology. They are not of intermediate or high probability of concern for malignancy. |
|||
|
Growing within a cystic adenoma, filling the cavity with a mass of branching epithelial processes |
Retired. Replaced by (47488001, SCT, "Intracystic papilloma"). |
||
|
Adenoma located in mammary duct, present as discrete sclerotic nodules, solitary or multiple. |
|||
|
The occurrence of fibrous tumor-forming stromal proliferation in patients with diabetes mellitus. |
|||
|
A deep seated firm tumor frequently occurring on the chest consisting of collagenous tissue that infiltrates surround muscle; frequently recurs but does not metastasize |
Retired. Replaced by (47284001, SCT, "Extra abdominal desmoid"). |
||
|
A cyst formed of a mass of epithelial cells, as a result of trauma has been pushed beneath the epidermis. The cyst is lined with squamous epithelium and contains concentric layers or keratin |
Retired. Replaced by (419670003, SCT, "Epidermal inclusion cyst"). |
||
|
Retired. Replaced by (37058002, SCT, "Foreign body (reaction)"). |
|||
|
Retired. Replaced by (42385006, SCT, "Galactocele"). |
|||
|
A congenital anomaly that leads to a proliferation of blood vessels leading to a mass that resembles a neoplasm, not located in parenchymal areas but subcutaneous |
Retired. Replaced by (93473009, SCT, "Hemangioma of subcutaneous tissue"). |
||
|
Retired. Replaced by (76197007, SCT, "Hyperplasia, usual"). |
|||
|
A form of fibrocystic disease in young woman with florid and sclerosing adenosis that microscopically may suggest carcinoma. |
|||
|
Enlarging masses during lactation. A circumscribed benign tumor composed primarily of glandular structures with scanty stroma, with prominent secretory changes in the duct |
Retired. Replaced by (128651002, SCT, "Lactating adenoma"). |
||
|
Solitary or multiple tumors of muscles and fibrous tissues, or tumors composed of myofibroblasts |
Retired. Replaced by (128738002, SCT, "Myofibroblastoma"). |
||
|
Irregular clusters of small tubules are present in adipose or fibrous tissue, resembling tubular carcinoma but lacking stromal fibroblastic proliferation. |
|||
|
Papilloma typically involving an aggregate of adjacent ducts in the periphery of the breast, likely representing involvement of several foci of one or two duct systems. |
|||
|
Condition in which there are tumors of various sizes on peripheral nerves. They may be neuromas or fibromas |
Retired. Replaced by (81669005, SCT, "Neurofibromatosis"). |
||
|
A cyst resulting from the loss of the epithelial lining of a sebaceous dermoid or lacteal cyst. |
|||
|
Breast tissue with characteristics of a benign nature, following breast reduction surgery. |
|||
|
A benign stromal lesion composed of intermixed stromal and epithelial elements. The lobular and duct structures of the breast parenchyma are separated by an increased amount of stroma, non specific proliferative epithelial changes include hyperplasia of duct and lobular epithelium often with accentuation of myoepithelial cells and aprocine metaplasia with or without cyst formation. |
|||
|
An nonencapsulated stellate lesion consisting of a fibroelastic core and radiating bands of fibrous connective tissue containing lobules manifesting adenosis and ducts with papillary or diffuse intraductal hyperplasia |
Retired. Replaced by (133855003, SCT, "Radial scar"). |
||
|
Retired. Replaced by (50916005, SCT, "Sclerosing adenosis"). |
|||
|
Nodular inflammatory lesions due to the presence of silicone in the breast tissue. |
|||
|
Spontaneous excessive proliferation of breast tissue, usually found in younger women. |
|||
|
A malignant neoplasm occurring most often in breast and skin, believed to originate from endothelial cells of blood vessels, microscopically composed of closely packed round or spindle shaped cells, some of which line small spaces resembling vascular clefts |
Retired. Replaced by (39000009, SCT, "Angiosarcoma"). |
||
|
Histological changes to the vascular system related to an invasive process. |
|||
|
Carcinoma of the breast found in patients less than 20 years of age. |
|||
|
A carcinoma found in supernumerary breasts and aberrant breast tissue. |
|||
|
A carcinoma that synthesizes substances, including hormones, not considered to be normal products of the breast. |
|||
|
A basal cell carcinoma that arises in the nipple of the breast. |
|||
|
Retired. Replaced by (22694002, SCT, "Carcinoma with metaplasia"). |
|||
|
Carcinoma of the breast presenting during pregnancy or lactation. |
|||
|
A malignant neoplasm that contains elements of carcinoma and sarcoma, so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue |
Retired. Replaced by (63264007, SCT, "Carcinosarcoma"). |
||
|
A non-invasive carcinoma restricted to the glandular lumen characterized by less aggressive malignant cytologic features and behavior. |
|||
|
Retired. Replaced by (128696009, SCT, "Intraductal carcinoma micro-papillary"). |
|||
|
A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells found in a cyst. |
|||
|
Carcinoma with both characteristics of localized and spreading disease. |
|||
|
Retired. Replaced by (89740008, SCT, "Invasive lobular carcinoma"). |
|||
|
Mammary infiltrates as a secondary manifestation in patients with established leukemia. |
|||
|
Histological changes to the lymphatic system related to an invasive process. |
|||
|
A heterogeneous group of neoplasms arising in the reticuloendoethelial and lymphatic systems |
Retired. Replaced by (1163043007, SCT, "Lymphoma"). |
||
|
Occult carcinoma presenting with axillary lymph node metastases |
A small carcinoma, either asymptomatic or giving rise to metastases without symptoms due to the primary carcinoma presenting with metastatic disease in the axillary lymph nodes. |
||
|
A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a non-mammary malignant neoplasm. |
|||
|
A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the colon. |
|||
|
A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the lung. |
|||
|
A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a melanoma. |
|||
|
A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a neoplasm in the ovary. |
|||
|
A malignant lesion in the breast with morphologic patterns not typical of breast carcinoma arising from a sarcoma. |
|||
|
Multiple foci of non-invasive carcinoma restricted to the glandular lumen. |
|||
|
A malignant lesion in an axillary node arising from a non-axillary neoplasm. |
|||
|
Retired. Replaced by (34360000, SCT, "Malignant fibrous histiocytoma"). |
|||
|
A malignant lesion in a intramammary lymph node arising from a non-intramammary lymph node neoplasm. |
|||
|
A malignant melanoma of the skin that arises in the nipple of the breast. |
|||
|
Retired. Replaced by (126510002, SCT, "Neoplasm of the mammary skin"). |
|||
|
Retired. Replaced by (10376009, SCT, "Papillary carcinoma in-situ"). |
|||
|
Squamous cell carcinoma to the terminal portion of the alveolar. |
|||
|
A non-invasive carcinoma restricted to the glandular lumen characterized by more aggressive malignant cytologic features and behavior. |
|||
|
Retired. Replaced by (30156004, SCT, "Invasive cribriform carcinoma"). |
|||
|
An indication that some or all of the margin of a lesion has sharp corners, often forming acute angles. |
|||
|
Calcifications that vary in sizes and shapes and are usually smaller than0.5 mm in diameter. |
|||
|
An indicator that calcifications are imbedded within a mass. |
|||
|
An indicator that calcifications are imaged outside of a mass finding. |
|||
|
Fat lobules and uniformly echogenic bands of supporting structures comprise the bulk of breast tissue. |
|||
|
A uniformly echogenic layer of fibroglandular tissue is seen beneath a thin layer of subcutaneous fat. |
|||
|
The breast texture is characterized by multiple small areas of increased and decreased echogenicity. |
|||
|
Referential relationship of the finding to the imaging device as noted on sonography. |
|||
|
The long axis of a lesion parallels the skin line ("wider-than-tall" or in a horizontal orientation). |
|||
|
The anterior-posterior or vertical dimension is greater than the transverse or horizontal dimension. |
|||
|
The lesion boundary describes the transition zone between the mass and the surrounding tissue. |
|||
|
The sharp demarcation between the lesion and surrounding tissue can be imperceptible or a distinct well-defined echogenic rim of any thickness. |
|||
|
There is no sharp demarcation between the mass and the surrounding tissue, which is bridged by an echogenic transition zone. |
|||
|
An imaging characteristic of resonance noted during sonography. |
|||
|
Having increased echogenicity relative to fat or equal to fibroglandular tissue. |
|||
|
Defined relative to fat; masses are characterized by low-level echoes throughout. E.g., appearance of a complicated cyst or fibroadenoma. |
|||
|
Having the same echogenicity as fat (a complicated cyst or fibroadenoma may be isoechoic or hypoechoic). |
|||
|
The attenuation characteristics of a mass with respect to its acoustic transmission. |
|||
|
More than one pattern of posterior attenuation, both shadowing and enhancement. |
|||
|
|